1. Home
  2. ENSC vs ICON Comparison

ENSC vs ICON Comparison

Compare ENSC & ICON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENSC
  • ICON
  • Stock Information
  • Founded
  • ENSC 2003
  • ICON 2023
  • Country
  • ENSC United States
  • ICON Greece
  • Employees
  • ENSC N/A
  • ICON N/A
  • Industry
  • ENSC Biotechnology: Pharmaceutical Preparations
  • ICON
  • Sector
  • ENSC Health Care
  • ICON
  • Exchange
  • ENSC Nasdaq
  • ICON Nasdaq
  • Market Cap
  • ENSC 3.4M
  • ICON 3.6M
  • IPO Year
  • ENSC N/A
  • ICON 2024
  • Fundamental
  • Price
  • ENSC $2.38
  • ICON $1.68
  • Analyst Decision
  • ENSC
  • ICON Strong Buy
  • Analyst Count
  • ENSC 0
  • ICON 1
  • Target Price
  • ENSC N/A
  • ICON $4.50
  • AVG Volume (30 Days)
  • ENSC 455.1K
  • ICON 62.0K
  • Earning Date
  • ENSC 05-13-2025
  • ICON 06-17-2025
  • Dividend Yield
  • ENSC N/A
  • ICON 206.67%
  • EPS Growth
  • ENSC N/A
  • ICON N/A
  • EPS
  • ENSC N/A
  • ICON N/A
  • Revenue
  • ENSC $6,224,081.00
  • ICON $5,309,000.00
  • Revenue This Year
  • ENSC N/A
  • ICON $76.76
  • Revenue Next Year
  • ENSC $1,381.48
  • ICON $30.43
  • P/E Ratio
  • ENSC N/A
  • ICON N/A
  • Revenue Growth
  • ENSC 256.35
  • ICON 18.61
  • 52 Week Low
  • ENSC $1.62
  • ICON $1.60
  • 52 Week High
  • ENSC $14.67
  • ICON $154.00
  • Technical
  • Relative Strength Index (RSI)
  • ENSC 49.99
  • ICON N/A
  • Support Level
  • ENSC $2.12
  • ICON N/A
  • Resistance Level
  • ENSC $2.57
  • ICON N/A
  • Average True Range (ATR)
  • ENSC 0.21
  • ICON 0.00
  • MACD
  • ENSC 0.04
  • ICON 0.00
  • Stochastic Oscillator
  • ENSC 53.87
  • ICON 0.00

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About ICON Icon Energy Corp. Common stock

Icon Energy Corp is a Growth-oriented company that operates as a holding company for the purpose of acquiring, owning, chartering and operating dry bulk vessels through its subsidiaries. The company generates its revenues by chartering the Initial Vessels to regional and international dry bulk operators, commodity traders and end users.

Share on Social Networks: